Privately held DOBI Medical Systems announced that it has arranged for $12 million in private equity with Sterling Financial Investment Group of Boca Raton, FL. The money will be used to further the engineering, design, and clinical testing of
Privately held DOBI Medical Systems announced that it has arranged for $12 million in private equity with Sterling Financial Investment Group of Boca Raton, FL. The money will be used to further the engineering, design, and clinical testing of DOBI's patented breast cancer diagnosis system.
The Dynamic Optical Breast Imaging (DOBI) system recently commenced clinical tests as an investigational device at a number of sites in the U.S.
The DOBI system will be used initially as an adjunct to traditional mammography. It operates by detecting the effects of increased vascularization (angiogenesis) associated with the growth of malignant lesions.
Breast MRI and Background Parenchymal Enhancement: What a Meta-Analysis Reveals
May 29th 2025Moderate or marked background parenchymal enhancement (BPE) reduces the sensitivity and specificity of MRI for breast cancer detection by more than 10 percent in comparison to scans with minimal or mild BPE, according to a new meta-analysis.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.